Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1617
    -0.0066 (-0.57%)
     
  • GBP/USD

    1.2374
    -0.0064 (-0.52%)
     
  • Bitcoin GBP

    52,053.65
    +1,386.87 (+2.74%)
     
  • CMC Crypto 200

    1,387.75
    +75.13 (+5.72%)
     
  • S&P 500

    4,980.95
    -30.17 (-0.60%)
     
  • DOW

    37,986.75
    +211.37 (+0.56%)
     
  • CRUDE OIL

    83.30
    +0.57 (+0.69%)
     
  • GOLD FUTURES

    2,408.80
    +10.80 (+0.45%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Should You Think About Buying CDK Global, Inc. (NASDAQ:CDK) Now?

While CDK Global, Inc. (NASDAQ:CDK) might not be the most widely known stock at the moment, it saw a decent share price growth in the teens level on the NASDAQGS over the last few months. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s examine CDK Global’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

Check out our latest analysis for CDK Global

What's the opportunity in CDK Global?

Great news for investors – CDK Global is still trading at a fairly cheap price according to my price multiple model, where I compare the company's price-to-earnings ratio to the industry average. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 24.62x is currently well-below the industry average of 45.46x, meaning that it is trading at a cheaper price relative to its peers. What’s more interesting is that, CDK Global’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What kind of growth will CDK Global generate?

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 28% over the next year, the near-term future seems bright for CDK Global. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? Since CDK is currently trading below the industry PE ratio, it may be a great time to increase your holdings in the stock. With a positive profit outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current price multiple.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on CDK for a while, now might be the time to make a leap. Its buoyant future profit outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy CDK. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. Be aware that CDK Global is showing 2 warning signs in our investment analysis and 1 of those is a bit unpleasant...

If you are no longer interested in CDK Global, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.